Northwest Biotherapeutics Inc (QB) (NWBO) News

How many friday we got a spike? Only to come crashing the ff week. People here either idiot to not remember the pattern or just dilutional.

24% spike signal approval? Who you kidding with? This spike literally nothing signifies.

As if no paid announcement from your local pumpers department as well. Approval next week? YEAH RIGHT! Nice try!

Who's in the right mind would think that if the share price hit .17 means news is coming? Are you out of your mind to believe that? You probably one of the flat earther people. I can't believe I'm reading this. smfh

Immunotherapy has advanced tremendously in the last 15 years. Part of the advancement came from this trial. NWBO and Roswell continue to lead the advancements and have clearly joined forces to fight cancer. Many other forces continue to be focused on profits.

manibiotech,

News doesn’t always leak but anticipation can become stronger and the target mentioned by some of $.17 was reached before someone anticipated news it seems. Some speculated March CHM meeting and April news. Others think April CHM and May news. At some point the questions stop was what was reported as happening before the MIA approval. Maybe someone thinks the questions have stopped by now. Best wishes.

And when I argued some time ago that we will see volume and SP go up in days ahead of any news , you are the one that argued that news don't always leak .

Looks more like it unless there is a follow through next few days . We have seen this pumped closed to $1 and brought right down few times in past . We are at 24  cents for crying out loud. Also another possibility is some financier bought shares at discount and brings the price up to sell them , which we have seen in past . So unless there is a follow through this coming week or some news , who knows.

JTORENCE,

The ASM? Well if ASCO is any indication, they might be too busy to attend; ). Best wishes.

Wow!, they are seriously bringing up pseudoprogression again? I thought this was put to bed 3 years ago at least. I guess changing endpoints is next in the cycle

learningcurve2020,

I guess you missed the part about big pharma research back in 2014 indicating that their checkpoint inhibitors would be improved upon dramatically by dendritic cell therapy. Yes, L being part of a combo and monetized was a thought back then, just not a thought valued properly because L and Direct were not more fully understood then as a real rather than potential threat. Now the threat is unmistakable; ). Best wishes.

Will Northwest Biotherapeutics (NWBO) issue a press release on Monday regarding a trading halt on Börse Stuttgart?
Highly unlikely—99.999% chance it won’t happen.

However, if NWBO does release a PR on Monday, it would boost my confidence in management, and I’d buy more shares.

x,

There is also an active clinical trial for ovarian cancer with the Roswell DC platform:


https://clinicaltrials.gov/study/NCT02432378


https://aimimmuno.com/immuno-oncology-2/


https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-exclusive-in-license-of-portfolio-of-dendritic-cell-technology-and-intellectual-property-302174237.html

Running my own post through Gemini
The information you've provided touches on some real aspects of cancer treatment and the potential effects of immunotherapies like DCVax-L. Let's break down each part:
* Tumors shrink with radiation and chemotherapy: This is generally true. Radiation and chemotherapy are designed to directly kill cancer cells or damage their DNA to prevent further growth, often leading to tumor shrinkage.
* Tumors swell when there is an immune response within tumor. Definitely a result of DCVax-L: It is true that an immune response within a tumor can cause it to swell. This happens because immune cells infiltrate the tumor site to attack the cancer cells. DCVax-L is an immunotherapy designed to stimulate an immune response against the tumor, so it is plausible that swelling could occur as a result of its action.
* This was misunderstood 10 years ago and why they mistakenly thought the tumor was progressing: This refers to a phenomenon known as pseudoprogression. In some cases, particularly with immunotherapies, a tumor might initially appear to grow larger on imaging scans due to the influx of immune cells, even though the therapy is actually working to kill the cancer cells. This can be mistaken for true tumor progression if not properly understood. This phenomenon has become more recognized in the field of oncology over the past decade as immunotherapy has become more prevalent.
* Given time the tumor implodes! Is this true? The term "implodes" isn't the standard medical term used to describe how a tumor disappears after successful treatment. However, the underlying concept is that if the immune response stimulated by DCVax-L is effective, it can eventually lead to the destruction and elimination of the tumor. This process would typically be described as tumor regression or tumor resolution, rather than "implosion."
In summary:
The statement contains elements of truth. Tumors can indeed swell due to an immune response stimulated by therapies like DCVax-L, and this swelling can sometimes be mistaken for tumor progression (pseudoprogression). This understanding has evolved over time in the medical field. While the term "implodes" isn't a standard medical term, it likely refers to the desired outcome of successful immunotherapy, which is the eventual disappearance of the tumor.
It's important to note that the effectiveness of DCVax-L and the occurrence of pseudoprogression can vary depending on the type of cancer, the individual patient, and other factors. Treatment outcomes should always be discussed with a qualified medical professional who can provide personalized advice based on the specific situation.

A paid announcement from your local Market Makers.

Yes, big dilution coming Monday.

They have run an ovarian cancer trial but had to stay focused on GBM because funding has been an issue as you well know.
Well, to get a little more detail on the Ovarian trial issue.

The P1 trial with DCvax-L in ovarian , NCT00683241 was actually run by G Coukos at U Pen. with NWBO a collaborator. It was completed back in 2009.

They had already listed a second trial, a P1/2, but that was cancelled shortly after the results of the first. Then Coukos U Pen went ahead with other DC vaccine trials using different technology.

Sounds like Couko's decision was not based on money but on the tech he saw as the better choice.

exwannabe,

If you don’t believe unexplained moves are rare and that what you suggest would, under normal circumstances, have been warned about ahead of time then it seems you are not suggesting a likely scenario. Best wishes.

What, and miss out on all the great speculation, hope, and FUD thats being passed around? My question is, will there be news early monday morning since German exchange is 7 hrs(?) ahead of us. I still believe a company should contact the exchange to see why the halt and let investors know. Also with 24% SP increase, I wonder if they will dilute more than their usual million shares monday morning?

Maybe just wait and see if there is news on Monday before going down a rabbit hole.

Mid day on Friday there were 10,000 or less shares available to short, MM's needed shares badly according to the 100 share size sells (Ton of them occurred on Friday) Please do not loan out your shares!

Tumors shrink with radiation and chemotherapy. Tumors swell when there is an immune response within tumor. Definitely a result of DCVax-L. This was misunderstood 10 years ago and why they mistakenly thought the tumor was progressing. Given time the tumor implodes!
You know this LC. Stop lying.

Looks most likely like a Mountain men Mike & Andrew Reddit pump.

Ever consider the possibility that the decision was due to the fact that they do not make money quoting a stock that basically does not trade?

There is no listing fee there. So the only reason they have to quote a stock is the tiny cut they get off the trades made in their system. And for NWBO this could not have amounted to anything of note.

I actually posted similarly but my post was deleted by one of the moderators. Maybe it was because I lamented the absence of one of the less-optimistic posters from the board all day. Wonder who that could have been.

"Regulation (EU) No. 596/2014 (the Market Abuse Regulation): this Regulation aims to combat insider trading and market manipulation. Together with Directive 2014/57/EU (the Market Abuse Directive), which sets out criminal sanctions for market abuse, it forms the European legal framework against market abuse. The three main subject areas of the Market Abuse Regulation are the prohibition of insider trading, the timely disclosure of inside information by issuers and the prevention and combat of market manipulation."

another possible answer

The company’s never been able to get “The German Issue” off their books for some reason so maybe it has to do with that? 🤷‍♀️

"The operator of a multilateral or organised trading facility (“trading venue operator”) can suspend trading with a financial instrument or remove this instrument from trading if this appears necessary in order to ensure orderly trading or to protect investor interests (section 73 (1) sentence 1 of the German Securities Trading Act (Wertpapierhandelsgesetz – WpHG)). This applies in particular if

the financial instrument no longer complies with the rules of the trading facility,
there is a suspicion of market abuse within the meaning of Article 1 of the Market Abuse Regulation (Regulation (EU) No 596/2014 – MAR) or the non-disclosure of inside information infringing Article 17 of the MAR in respect of the financial instrument, or
a takeover bid has been published in relation to the issuer of the financial instrument. If the trading venue operator suspends trading with financial instruments or removes these instruments from trading under section 73 (1) sentence 1 of the WpHG, they must also suspend trading in derivatives related to those financial instruments or remove the financial instruments in question from trading (section 73 (1) sentence 2 of the WpHG)."

from BaFin

Anyone know if the low share price would cause the halt in stugart? Someone mentioned it in a group chat? Hoping not the case

So when is the ASM?? LOL

He said he was speculating same as everyone here including you. Nobody knows what is going until we hear something from company. The progress report is overdue.

And, an actual Annual Report!

https://d18rn0p25nwr6d.cloudfront.net/CIK-0000886744/bad7fcef-4402-41a7-9a83-9afc15424cf4.pdf

I am ok with the fact that I may be wrong
It's just a possibility.

I have no idea if I'm correct.
And I don't care what you're thinking.

Everyone here is just guessing but you seem to know everything.

For the rest of the day, I will be busy counting all my shares, it will take that long.

Again have a great weekend. - It just came to me I never said it was positive news LOLOLOL

“L is seen as the funding source for Direct.” 🤣🤣🤣🤷‍♀️

I think you are wrong again :
The last trade for NWBO in Germany was Wed, April 9.
No indication the market was closed, it is pure speculation from
you, probably just to heat up further speculation

The main question is, is this good news or bad news?
I'm leaning towards bad, thinking NWBO did something wrong and german exchange is looking into it. Why else suspend and cancel orders? To say there were too many orders to handle has got to be BS. That would not allow an exchange to cancel orders.
If it was good news and leaked to one exchange and/or that exchange was notified before everyone else, wouldn't that be considered insider trading?
As long as we're speculating, it could be a massive MM attack. An accusation against NWBO, filed in german market to get them to halt while they investigate. Then claim its bad news and wait for SP to drop.
It could also be a merger and name change situation, but that would be an event that would have to be PR'd.
SP up 24% with good volume, another clue or FOMO?
No trades in german market on thurs, then halt and cancelling orders on friday. The no trades on thurs has me worried. If they were notified friday of some big news, then why no trades on thur?
I was going to stop posting friday without news, but this is a whole new chapter in the NWBO conspiracy novel.
You would think an event big enough to get them halted on an exchange would be worthy of a PR, unless company had nothing to do with it. But a CEO of a company should contact german market and see why they are halted, and pass that info on to shareholders, who are skittish enough allready.
In the words of artie johnson on "laugh in", "very interesting"....

learningcurve2020,

They have run an ovarian cancer trial but had to stay focused on GBM because funding has been an issue as you well know. DCVax is a huge threat that big pharma has not wanted to see advance because of what funding Direct, without them controlling, would do to them. L is seen as the funding source for Direct. This is not difficult to figure out. Slow L means slowing Direct which means more profits from checkpoint inhibitors, chemo and radiation in the mean time. Best wishes.

take a look at the CMF on the 30 minute

What a joke, the pumpers are getting truly desperate for anything to pump as they realize that the approval is not going to happen and they need to juice the price to cash out w/o a huge loss.

As far as the companies having ties, I doubt the Germans are fond of the the US company created when the US seized all German assets in the US. And as far as somehow the Stugart market action means anything, it doesn't.

As bad as the constant assertions that the trial hold in 2015 had something to do with the German RA just because the news was first found on their site.

learningcurve2020,

If you understood the science you would know the mystery is being solved and issues targeted. Those who study these things can actually figure out what needs to be done many years before “the process” allows patients to benefit and that is a big problem for patients and any small company trying to run the gauntlet created by it to favor big pharma in that intervening time. NWBO and Linda Powers found a way to move discovery forward without big pharma or status quo oversight stopping it.
For as much as you claim to hate what has been done by big pharma with Covid vaccines it’s amazing that you can’t understand that you have been supporting them against true progress. Then again, many simply do not understand the science NWBO is working with or the way it is usually controlled for our “best interest” by the status quo the way Ken Griffen says he and his buddies should control company valuations because the are so smart and have great due diligence.
I guess you need decide who you really trust because right now you are speaking against but acting in line with those you say are a problem; ). Best wishes.

GERN has been taken down aggressively over the past several months, as someone has been trying to pry shares loose. They were approved in the U.S. in May and recently in the EU for MDS. They are currently ramping sales and should break even within a couple quarters. GERN has two other indications coming down the pipeline, and their telomerase inhibitor treatment could be used in combination. They have a large institutional ownership, and are sitting on a blockbuster drug.

Trading of Northwest Biotherapeutics (NWBO) on the Stuttgart Stock Exchange was reportedly halted on April 11, 2025, around 13:57 CEST, with no official reason provided by the exchange. Orders were canceled, and trading did not resume that day. Meanwhile, NWBO continued trading on the U.S. OTCQB market, where it surged 22.67% on the same day, driven by heavy buying volume. Some speculate the halt in Stuttgart may be linked to the exchange’s inability to handle large buy orders, as OTCQB saw over 5 million shares traded on April 10 and 3.6 million by mid-morning on April 11. However, without an official statement from Börse Stuttgart, the exact cause remains unclear.

OK, should we assume that nobody communicates between the two related companies?
Management does not speak to each other, not even in the board rooms.

Can we assume that nobody in Merck & Co., Inc. an American pharma co. does not have any ties in Germany?
Maybe nothing, maybe something.
Some day we will find out

It was just another speculation, nobody knows anything about why the larger volume last Friday.
Not even You

Whatever is going on, ITS' GOING TO BE VERY BIG NEWS

All we know is the market on Northwest Bio was closed in Germany last Friday.

Have a Great Saturday and Sunday!

This is utter BS ...

- Merck KGaA is a german pharma - and chemical company
- Merck & Co., Inc. is an american pharma co.

It could well be they were related in the past, but today these two
companies are independant of each other, so you better do some DD
before posting. TIA

learningcurve2020,

Nope, but there will be consolidation and golden parachutes. You know how this works.. or should by now. Best wishes.

Post
Christalbal
@Christalball93
Holy shit! Citadel Derivatives caught #spoofing very bottom of #Tesla order book, @elonmusk, @doge_sec! 👀 #christalballexposures

Holy shit! Citadel Derivatives caught #spoofing very bottom of #Tesla order book, @elonmusk, @doge_sec! 👀 #christalballexposures pic.twitter.com/MJoRhFmRFI— Christalball (@Christalball93) April 10, 2025

That’ll be the same day that every Big Pharma CEO loses their job because they failed to see what you see so clearly. 🙄🤷‍♀️

Always be leery of someone who starts off with “Thank you for agreeing with my point”. I didn’t, of course. It’s just that you twisted up my initial post into one of your famous pretzels so we ended up talking about swelling. I was talking about quickly getting a treatment because one doesn’t have much time to lose with GBM.

Many patients who received L didn’t even respond so the idea that you can play with its potency is like saying you can fry an egg on a cold stove. L is made to present hundreds of antigens unlike mRNA and T cell therapies that only present one or a few, so I’d say that’s about as aggressive as it gets. Why it doesn’t work better is a still a mystery? Why they’ve never run trials on other solid cancer without the bbb obstacle is still a mystery?

Interestingly, Merck is a German company, as everyone knows!!!!

And it was the German exchange that was halted !!

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries.

Is Geron halted too, or just northwest biotheraputics?